Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Dose Comparison in IPACK Block for Knee Arthroplasty
NCT05963139Completed
- Sponsor
- Istanbul University
- Start
- Aug 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in postoperative pain, sponsored by Istanbul University. Primary endpoints: Numeric Rating Scale Pain Score at 48 hours and Total Morphine Consumption at 48 hours. Started Aug 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05963139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05963139.